DAVID B. WELLS - 13 May 2025 Form 4 Insider Report for Trade Desk, Inc. (TTD)

Role
Director
Signature
/s/ Kelli Faerber, Attorney-In-Fact for David B. Wells
Issuer symbol
TTD
Transactions as of
13 May 2025
Net transactions value
-$618,547
Form type
4
Filing time
15 May 2025, 17:05:25 UTC
Previous filing
17 Dec 2024
Next filing
16 Jun 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
WELLS DAVID B Director C/O THE TRADE DESK, INC., 42 NORTH CHESTNUT STREET, VENTURA /s/ Kelli Faerber, Attorney-In-Fact for David B. Wells 15 May 2025 0001507645

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTD Class A Common Stock Options Exercise $408,621 +6,990 +10% $58.46 73,975 13 May 2025 Direct
transaction TTD Class A Common Stock Options Exercise $81,257 +1,390 +1.9% $58.46 75,365 13 May 2025 Direct
transaction TTD Class A Common Stock Options Exercise $39,167 +670 +0.89% $58.46 76,035 13 May 2025 Direct
transaction TTD Class A Common Stock Options Exercise $12,861 +220 +0.29% $58.46 76,255 13 May 2025 Direct
transaction TTD Class A Common Stock Options Exercise $334,679 +6,826 +9% $49.03 83,081 13 May 2025 Direct
transaction TTD Class A Common Stock Options Exercise $66,926 +1,365 +1.6% $49.03 84,446 13 May 2025 Direct
transaction TTD Class A Common Stock Options Exercise $32,115 +655 +0.78% $49.03 85,101 13 May 2025 Direct
transaction TTD Class A Common Stock Options Exercise $10,689 +218 +0.26% $49.03 85,319 13 May 2025 Direct
transaction TTD Class A Common Stock Options Exercise $482,505 +7,282 +8.5% $66.26 92,601 13 May 2025 Direct
transaction TTD Class A Common Stock Options Exercise $91,041 +1,374 +1.5% $66.26 93,975 13 May 2025 Direct
transaction TTD Class A Common Stock Options Exercise $91,041 +1,374 +1.5% $66.26 95,349 13 May 2025 Direct
transaction TTD Class A Common Stock Options Exercise $18,155 +274 +0.29% $66.26 95,623 13 May 2025 Direct
transaction TTD Class A Common Stock Sale $2,287,603 -28,638 -30% $79.88 66,985 13 May 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TTD Stock Option (Right to Buy) Options Exercise $0 -6,990 -100% $0.000000 0 13 May 2025 Class A Common Stock 6,990 $58.46 Direct F3, F4
transaction TTD Stock Option (Right to Buy) Options Exercise $0 -1,390 -100% $0.000000 0 13 May 2025 Class A Common Stock 1,390 $58.46 Direct F4, F5
transaction TTD Stock Option (Right to Buy) Options Exercise $0 -670 -100% $0.000000 0 13 May 2025 Class A Common Stock 670 $58.46 Direct F6, F7
transaction TTD Stock Option (Right to Buy) Options Exercise $0 -220 -100% $0.000000 0 13 May 2025 Class A Common Stock 220 $58.46 Direct F8, F9
transaction TTD Stock Option (Right to Buy) Options Exercise $0 -6,826 -100% $0.000000 0 13 May 2025 Class A Common Stock 6,826 $49.03 Direct F10
transaction TTD Stock Option (Right to Buy) Options Exercise $0 -1,365 -100% $0.000000 0 13 May 2025 Class A Common Stock 1,365 $49.03 Direct F10
transaction TTD Stock Option (Right to Buy) Options Exercise $0 -655 -100% $0.000000 0 13 May 2025 Class A Common Stock 655 $49.03 Direct F11
transaction TTD Stock Option (Right to Buy) Options Exercise $0 -218 -100% $0.000000 0 13 May 2025 Class A Common Stock 218 $49.03 Direct F12
transaction TTD Stock Option (Right to Buy) Options Exercise $0 -7,282 -100% $0.000000 0 13 May 2025 Class A Common Stock 7,282 $66.26 Direct F13
transaction TTD Stock Option (Right to Buy) Options Exercise $0 -1,374 -100% $0.000000 0 13 May 2025 Class A Common Stock 1,374 $66.26 Direct F13
transaction TTD Stock Option (Right to Buy) Options Exercise $0 -1,374 -100% $0.000000 0 13 May 2025 Class A Common Stock 1,374 $66.26 Direct F14
transaction TTD Stock Option (Right to Buy) Options Exercise $0 -274 -100% $0.000000 0 13 May 2025 Class A Common Stock 274 $66.26 Direct F15
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These sales represent the aggregate shares from the twelve acquisitions reported above.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.88 to $79.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 This option was previously reported as covering 699 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021.
F4 The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date.
F5 This option was previously reported as covering 139 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021.
F6 This option was previously reported as covering 67 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021.
F7 The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date.
F8 This option was previously reported as covering 22 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021.
F9 The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date.
F10 The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date.
F11 The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date.
F12 The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date.
F13 The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date.
F14 The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date.
F15 The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date.